Gottfried Schlaug to Fibrinolytic Agents
This is a "connection" page, showing publications Gottfried Schlaug has written about Fibrinolytic Agents.
Connection Strength
0.413
-
Selim M, Fink JN, Kumar S, Caplan LR, Horkan C, Chen Y, Linfante I, Schlaug G. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume. Stroke. 2002 Aug; 33(8):2047-52.
Score: 0.176
-
Fink JN, Selim MH, Kumar S, Schlaug G. Why are stroke patients excluded from tPA therapy? An analysis of patient eligibility. Neurology. 2001 Nov 13; 57(9):1739-40.
Score: 0.168
-
Savitz SI, Schlaug G, Caplan L, Selim M. Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke. Stroke. 2005 Jul; 36(7):1447-51.
Score: 0.054
-
Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks MP. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol. 2006 Nov; 60(5):508-517.
Score: 0.015